Atypical Antipsychotic Exposure May Not Differentiate Metabolic Phenotypes of Patients with Schizophrenia

STUDY OBJECTIVE: Patients with schizophrenia are known to have higher rates of metabolic disease than the general population. Contributing factors likely include lifestyle and atypical antipsychotic (AAP) use, but the underlying mechanisms are unknown. The objective of this study was to identify met...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pharmacotherapy
Autori principali: Ward, Kristen M., Yeomans, Larisa, McHugh, Cora, Kraal, A. Zarina, Flowers, Stephanie A., Rothberg, Amy E., Karnovsky, Alla, Das, Arun, Ellingrod, Vicki L., Stringer, Kathleen A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014920/
https://ncbi.nlm.nih.gov/pubmed/29722909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.2119
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi